Cargando…
Ginkgol C17:1 inhibits tumor growth by blunting the EGF- PI3K/Akt signaling pathway
Ginkgol C17:1 has been shown to inhibit apoptosis and migration of cancer cells, but the underlying mechanisms are not fully elucidated. In this study, we explored whether the inhibitory effects of Ginkgol C17:1 were associated with epidermal growth factor receptor (EGFR) and PI3K/Akt signaling. The...
Autores principales: | Li, Yueying, Liu, Jun, Yang, Xiaoming, Dong, Yan, Liu, Yali, Chen, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460611/ https://www.ncbi.nlm.nih.gov/pubmed/28808215 http://dx.doi.org/10.7555/JBR.31.20160039 |
Ejemplares similares
-
Inhibitory effect of Ginkgol C17:1 on the biological behavior of tumor cells
por: Li, Yueying, et al.
Publicado: (2017) -
Effects of ginkgol C17:1 on cisplatin-induced autophagy and apoptosis in HepG2 cells
por: Liu, Jun, et al.
Publicado: (2018) -
Pharmacological Activities of Ginkgolic Acids in Relation to Autophagy
por: Ding, Yuan, et al.
Publicado: (2022) -
Regulation of EGF-stimulated activation of the PI-3K/AKT pathway by exocyst-mediated exocytosis
por: An, Seong J., et al.
Publicado: (2022) -
Ginkgolic acid inhibits the growth of renal cell carcinoma cells via inactivation of the EGFR signaling pathway
por: Zhu, Chao, et al.
Publicado: (2020)